26
|
Suzuki Y, Hong YH, Song SH, Ardiyanti A, Kato D, So KH, Katoh K, Roh SG. The Regulation of Chemerin and CMKLR1 Genes Expression by TNF-α, Adiponectin, and Chemerin Analog in Bovine Differentiated Adipocytes. ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES 2014; 25:1316-21. [PMID: 25049696 PMCID: PMC4092937 DOI: 10.5713/ajas.2012.12083] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/13/2012] [Revised: 06/24/2012] [Accepted: 03/23/2012] [Indexed: 01/14/2023]
Abstract
Adipokines, adipocyte-derived protein, have important roles in various kinds of physiology including energy homeostasis. Chemerin, one of adipocyte-derived adipokines, is highly expressed in differentiated adipocytes and is known to induce macrophage chemotaxis and glucose intolerance. The objective of the present study was to investigate the changes of chemerin and the chemokine-like-receptor 1 (CMKLR1) gene expression levels during differentiation of the bovine adipocyte and in differentiated adipocytes treated with tumor necrosis factor-α (TNF-α), adiponectin, leptin, and chemerin (peptide analog). The expression levels of the chemerin gene increased at d 6 and 12 of the differentiation period accompanied by increased cytoplasm lipid droplets. From d 6 onward, peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) gene expression levels were significantly higher than that of d 0 and 3. In contrast, CMKLR1 expression levels decreased at the end of the differentiation period. In fully differentiated adipocytes (i.e. at d 12), the treatment of TNF-α and adiponectin upregulated both chemerin and CMKLR1 gene expression levels, although leptin did not show such effects. Moreover, chemerin analog treatment was shown to upregulate chemerin gene expression levels regardless of doses. These results suggest that the expression of chemerin in bovine adipocyte might be regulated by chemerin itself and other adipokines, which indicates its possible role in modulating the adipokine secretions in adipose tissues.
Collapse
|
27
|
Kojima T, Takahashi N, Funahashi K, Kato D, Hattori Y, Hanabayashi M, Asai N, Ishiguro N. SAT0139 Importance of Concomitant MTX Use During Treatment with Tocilizumab in Patients with Rheumatoid Arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.1865] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
28
|
Hanabayashi M, Kojima T, Takahashi N, Funahashi K, Kato D, Hattori Y, Ishiguro N. SAT0118 The Clinical Outcome of Abatacept Treatment in Biologic NaÏVe Patients with Rheumatoid Arthritis in Multi-Center Clinical Practice. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.1844] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
29
|
Takashima H, Kurita A, Toda Y, Watanabe A, Waseda K, Kosaka T, Ando H, Sakurai S, Kato D, Amano T. Impact of right atrial pressure as venous pressure on fractional flow reserve calculation in patients with hemodialysis. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3970] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
30
|
Takashima H, Kurita A, Waseda K, Ando H, Kosaka T, Maeda K, Sakurai S, Kato D, Mizuno T, Amano T. Association between clustering of lesion morphology and functional ischemia of intermediate coronary stenosis in patients with stable angina pectoris. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.2865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
31
|
Funahashi K, Kojima T, Takahashi N, Kato D, Hattori Y, Hanabayashi M, Ishiguro N. THU0213 The Combination Therapy with Dose Escalation and Interval Shortening of Infliximab Makes Better Response to Patients with Rheumatoid Arthritis who Were Loss of Efficacy Against Infliximab. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
32
|
Kato D, Kojima T, Funahashi K, Takemoto T, Yoshioka Y, Watanabe T, Takahashi N, Hattori Y, Hanabayashi M, Ishiguro N. THU0233 To Achieve the Boolean/Sdai Remission, the Intra-Articular Steroid Injection is the Useful Application for Rheumatoid Arthritis Patients Close to Remission. –Clinical and Ultrasonographic Evaluation. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
33
|
Hattori Y, Kaneko A, Kojima T, Hirano Y, Fujibayashi T, Takahashi N, Funahashi K, Kato D, Matsubara H, Terabe K, Ishiguro N. AB0502 Serum matrix metalloproteinase-3 levels indicate c-reactive protein as one of boolean remission core measure sets in patients with rheumatoid arthritis by using anti-TNFα treatment. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
34
|
Kato D, Kojima T, Takahashi N, Funahashi K, Matsubara H, Hattori Y, Ishiguro N. AB0368 Epidemiology and therapeutic option of bacterial pneumonia in RA patients treated with biologics from multi-center registry in japan. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
35
|
Takahashi N, Kojima T, Funahashi K, Kato D, Matsubara H, Hattori Y, Ishiguro N. THU0117 Abatacept can demonstrate maximum efficacy without background methotrexate treatment in rheumatoid arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
36
|
Takahashi N, Kojima T, Funahashi K, Kato D, Matsubara H, Hattori Y, Ishiguro N. AB0563 Impact of the history and the type of previous biologic treatment on abatacept efficacy in rheumatoid arthritis patients. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
37
|
Kojima T, Funahashi K, Takahashi N, Kato D, Matsubara H, Hattori Y, Ishiguro N. AB0338 Improving of safety of treatment for the elderly patients with rheumatoid arthritis using biologics; results from over 2 years surveillance using multicenter registry in japan. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
38
|
Funahashi K, Kojima T, Takahashi N, Kato D, Matsubara H, Hattori Y, Ishiguro N. FRI0166 The effectiveness of shortening intervals of infliximab and dose escalation of infliximab with rheumatoid arthritis in multi-center clinical practice. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
39
|
Watanabe T, Kojima T, Takahashi N, Funahashi K, Kato D, Hattori Y, Hanabayashi M, Terabe K, Yoshioka Y, Ishiguro N. AB0793 Discordance between patients and physicians in their assessment of rheumatoid arthritis disease activity. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.3115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
40
|
Hattori Y, Kojima T, Takahashi N, Funahashi K, Kato D, Hanabayashi M, Ishiguro N. FRI0209 Comparison of serum matrix metalloproteinase-3 levels in rheumatoid arthritis after treatment with adalimumub or abatacept for 24 weeks. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
41
|
Kanayama Y, Kojima T, Hirano Y, Takahashi N, Funahashi K, Kato D, Matsubara H, Hattori Y, Yabe Y, Oishi Y, Ishiguro N. AB0585 Radiographic progression of cervical lesions and hands in patients with rheumatoid arthritis receiving tocilizumab treatment from japanese tbc registry. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
42
|
Kojima T, Funahashi K, Takahashi N, Kato D, Matsubara H, Hattori Y, Ishiguro N. AB0498 Mid-term clinical result of treatment with biologics in patients with rheumatoid arthritis to prevent structural damage of knee joints. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
43
|
Kojima T, Funahashi K, Takahashi N, Kato D, Matsubara H, Hattori Y, Yabe Y, Ishiguro N. THU0124 Importance of monitoring of C-reactive protein level to predict achievement of better clinical outcome during treatment with tocilizumab in patients with rheumatoid arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
44
|
Kanayama Y, Kojima T, Hirano Y, Takahashi N, Funahashi K, Kato D, Matsubara H, Hattori Y, Oishi Y, Ishiguro N. SAT0155 Radiographic progression of cervical lesions and hands in patients with rheumatoid arthritis receiving infliximab treatment from japanese tbc registry; two years of follow-up. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.3102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
45
|
Matsubara H, Kojima T, Takahashi N, Funahashi K, Kato D, Hattori Y, Ishiguro N. FRI0075 Etanercept treatment for the elderly patients with rheumatoid arthritis; using multicenter registry in japan. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
46
|
Viviani VR, Prado RA, Neves DR, Kato D, Barbosa JA. A route from darkness to light: emergence and evolution of luciferase activity in AMP-CoA-ligases inferred from a mealworm luciferase-like enzyme. Biochemistry 2013; 52:3963-73. [PMID: 23705763 DOI: 10.1021/bi400141u] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The origin of luciferases and of bioluminescence is enigmatic. In beetles, luciferases seem to have evolved from AMP-CoA-ligases. How the new oxygenase luminogenic function originated from AMP-ligases leading to luciferases is one of the most challenging mysteries of bioluminescence. Comparison of the cloned luciferase-like enzyme from the nonluminescent Zophobas morio mealworm and beetle luciferases showed that the oxygenase activity may have emerged as a stereoselective oxidative drift with d-luciferin, a substrate that cannot be easily thioesterified to CoA as in the case of the l-isomer. While the overall kcat displayed by beetle luciferases is orders of magnitude greater than that of the luciferase-like enzyme, the respective oxidation rates and quantum yields of bioluminescence are roughly similar, suggesting that the rate constant of the AMP-ligase activity exerted on the new d-luciferin substrate in beetle protoluciferases was the main enzymatic property that suffered optimization during the evolution of luciferases. The luciferase-like enzyme and luciferases boost the rate of luciferyl-adenylate chemiluminescent oxidation by factors of 10(6) and 10(7), respectively, as compared to the substrate spontaneous oxidation in buffer. A similar enhancement of luciferyl-adenylate chemiluminescence is provided by nucleophilic aprotic solvents, implying that the peptide bonds in the luciferin binding site of beetle luciferase could provide a similar catalytically favorable environment. These data suggest that the luciferase-like enzyme and other similar AMP-ligases are potential alternative oxygenases. Site-directed mutagenesis studies of the luciferase-like enzyme and the red light-producing luciferase of Phrixotrix hirtus railroadworm confirm here a critical role for T/S345 in luciferase function. Mutations such as I327T/S in the luciferase-like enzyme, which simultaneously increases luciferase activity and promotes blue shifts in the emission spectrum, could have been critical for evolving functional bioluminescence from red-emitting protoluciferases. Through the combination of I327T/S mutations and N-terminal fusion, the luminescence activity of this enzyme was increased to visible levels, with the development of a totally new orange-emitting luciferase. These results open the possibility of engineering luciferase activity in a set of AMP-CoA-ligases.
Collapse
|
47
|
Nishida A, Yamamoto H, Ohta Y, Karasawa M, Kato D, Uchida N, Wake A, Taniguchi S. T-cell post-transplant lymphoproliferative disorder in a patient with chronic idiopathic myelofibrosis following allogeneic PBSC transplantation. Bone Marrow Transplant 2009; 45:1372-4. [DOI: 10.1038/bmt.2009.347] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
48
|
Higuchi Y, Taketa M, Ohik T, Yasuhira K, Kawashima Y, Takeo M, Kato D, Negoro S, Nakagawa A, Inaka K, Tanaka H, Sato M, Kobayashi T, Tanaka T, Shibata N. Evolution of nylon oligomer degrading enzyme based on high-resolution crystal structure analysis. Acta Crystallogr A 2008. [DOI: 10.1107/s0108767308091782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
49
|
Seo S, Uchida N, Yamamoto H, Takagi S, Tsuji M, Kato D, Matsuno N, Masuoka K, Wake A, Taniguchi S. 375: The Analysis of Chronic GVHD after Cord Blood Transplantation in Comparison with Bone Marrow Transplantation. Biol Blood Marrow Transplant 2008. [DOI: 10.1016/j.bbmt.2007.12.385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
50
|
Wake A, Uchida N, Ishiwata K, Takagi S, Tsuji M, Kato D, Yamamoto H, Seo S, Matsuno N, Masuoka K, Miyakoshi S, Makino S, Yoneyama A, Taniguchi S. 134: Clinical Characteristics of Early Onset Non-Infectious Pulmonary Complications following Cord Blood Transplantation. Biol Blood Marrow Transplant 2008. [DOI: 10.1016/j.bbmt.2007.12.143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|